DMS Pharma Private Limited
About DMS Pharma Private Limited
Data last updated:
DMS Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 19 May 2022.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24100PN2022PTC211388.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Parashuram Suryawanshi and Madhuri Parshuram Suryawanshi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No.9 Motiram Complex S. No.81 Hissa No. 5A/1/2 Kothrud Paud Road, Pune, Maharashtra, India – 411038.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.3 Lakh, a decline of 19% compared to the previous year. For the same year it recorded a net loss of ₹21.41 Lakh (net margin -73.1%) and EBITDA of -₹15 Lakh (EBITDA margin -51.2%).
The company has about 22 employees on its provident fund (EPFO) records.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No.9 Motiram Complex S. No.81 Hissa No. 5A/1/2 Kothrud Paud Road, Pune, Maharashtra, India – 411038
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of DMS Pharma Private Limited
The main business activity of DMS Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of DMS Pharma Private Limited FY 2025 filings available
DMS Pharma Private Limited reported revenue of ₹29.3 Lakh (down 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of DMS Pharma Private Limited
Revenue fell 19% in the latest year. EBITDA rose 54% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of DMS Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | -₹15 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹21.41 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of DMS Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -51.2% | •••• | •••• |
| Net Profit Margin | -73.1% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of DMS Pharma are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of DMS Pharma Private Limited
DMS Pharma Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Unique Medichem Private Limited | ₹29.76 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Manesar, Haryana, India |
| Xpert Scientific Private Limited | ₹29.52 Lakh (FY 2023) | •••• | •••• | -29.0% | •••• | Vasai, Maharashtra, India |
| Leemedi Pharma Private Limited | ₹29.49 Lakh (FY 2025) | •••• | •••• | 7.0% | •••• | Delhi, India |
| Apextouch Artificial Limb Private Limited | ₹29.34 Lakh (FY 2024) | •••• | •••• | 2458.0% | •••• | Lucknow, Uttar Pradesh, India |
| Met India Equipments Private Limited | ₹29.33 Lakh (FY 2025) | •••• | •••• | -16.0% | •••• | New Delhi, Delhi, India |
| DMS Pharma Private Limited this company | ₹29.3 Lakh (FY 2025) | •••• | •••• | -19.0% | •••• | Pune, Maharashtra, India |
| Allabout Innovations Private Limited | ₹29.22 Lakh (FY 2023) | •••• | •••• | -95.0% | •••• | Alappuzha, Kerala, India |
| Diana Impex Pvt Ltd | ₹29.19 Lakh (FY 2025) | •••• | •••• | -67.0% | •••• | Kolkata, West Bengal, India |
| Good Hew Meditech Private Limited | ₹29.04 Lakh (FY 2022) | •••• | •••• | -92.0% | •••• | Kochi, Kerala, India |
| Pioneer Research Solutions (India) Private Limited | ₹28.63 Lakh (FY 2024) | •••• | •••• | -22.0% | •••• | Hyderabad, Telangana, India |
| Allen Ginsberg Laboratories Private Limited | ₹28.44 Lakh (FY 2025) | •••• | •••• | 18.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below DMS Pharma by revenue in the Healthcare industry (Medical and Laboratory Equipment), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of DMS Pharma Private Limited
DMS Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parashuram Suryawanshi Also directs: Shruseva Hospital LLP, West Mount Hospital LLP | Director | 19 Sep 2022 | 4 Years 0 Months | Current |
| Madhuri Parshuram Suryawanshi Also directs: West Mount Hospital LLP | Director | 19 May 2022 | 4 Years 4 Months | Current |
Charges & Borrowings of DMS Pharma Private Limited
DMS Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at DMS Pharma Private Limited
Employment history and EPFO contributions of people linked to DMS Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on DMS Pharma Private Limited
DMS Pharma Private Limited has 4 board changes on record since 2022: 2 appointments and 2 cessations. The latest: Parashuram Suryawanshi ceased to be Additional Director on 29 Sep 2023.
Credit Ratings, Litigation & Regulatory Alerts for DMS Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by DMS Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of DMS Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of DMS Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of DMS Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DMS Pharma Private Limited
DMS Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 19 May 2022 (4+ years old) and is registered under CIN U24100PN2022PTC211388.
DMS Pharma reported revenue of ₹29.3 Lakh for FY 2025 (down 19% YoY).
DMS Pharma has 2 current directors:
- Parashuram Suryawanshi - Director
- Madhuri Parshuram Suryawanshi - Director
DMS Pharma reported a net loss of ₹21.41 Lakh (net margin -73.1%) and EBITDA of -₹15 Lakh (EBITDA margin -51.2%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of DMS Pharma is U24100PN2022PTC211388. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
DMS Pharma was incorporated on 19 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Pune.
The peers of DMS Pharma by revenue are Unique Medichem Private Limited, Xpert Scientific Private Limited, Leemedi Pharma Private Limited, Apextouch Artificial Limb Private Limited, Met India Equipments Private Limited and 5 more, all in the Healthcare industry (Medical and Laboratory Equipment).
Parashuram Suryawanshi ceased to be Additional Director on 29 Sep 2023. Suraj Satish Suryavanshi ceased to be Director on 24 Nov 2022. Parashuram Suryawanshi was appointed as Director on 19 Sep 2022. DMS Pharma has 4 board changes on record in total.
The registered office of DMS Pharma is at Shop No.9 Motiram Complex S. No.81 Hissa No. 5A12 Kothrud Paud Road, Pune, Maharashtra, India – 411038.
DMS Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
DMS Pharma operates in the healthcare industry, in the medical and laboratory equipment segment.